‘Viagra,’ which had once held a commanding lead over the erectile dysfunction treatment market, is having trouble making a comeback. After being taken over by domestic generics Palpal,’ and ‘Sendom,’ it had also been outrun by another local generic, ‘Gugu.’ Lilly’s Cialis is also having trouble making a comeback due to generic competition.

According to the pharmaceutical research institution IQVIA, the oral erectile dysfunction treatment market in Q2 marked ₩29.5 billion, showing a 48% YOY increase. Also, this was a 3.1% increase from the previous quarter.

The erectile dysfunction treatment market had seen a reduction in sales in Q1 and Q2 of last year and had only started mak